Letrozole is an aromatase inhibitor widely used to treat breast cancer in postmenopausal women and has been a treatment option for hundreds of thousands of women since its approval in 1996. As its use expands, the risks of this drug, especially its contraindications during pregnancy, are rarely discussed. The potential risks of letrozole during pregnancy can be fatal to women and their unborn babies, which makes us wonder: in the pursuit of medical effects, have we ignored the long-term effects of these drugs? Influence?
Letrozole is primarily used to treat breast cancer, particularly in postmenopausal women whose breast cancer is hormone receptor positive. According to the U.S. Food and Drug Administration (FDA), letrozole is used to treat localized or metastatic breast cancer.
"Letrozole is shown to be more effective than statins in patients with early-stage breast cancer."
Although letrozole is effective in treating breast cancer, its use in pregnant women is contraindicated. This is because letrozole may cause harm to a developing fetus, especially during its early stages of development. If women take letrozole during pregnancy, it may cause heart defects and other congenital diseases.
Even low doses of letrozole are highly dangerous for pregnant women. According to studies, long-term use of letrozole is associated with a significantly increased risk of pregnancy-related complications, which is why healthcare professionals strongly recommend that female patients practice effective contraception during letrozole treatment.
"Women who are planning to become pregnant must discontinue letrozole treatment and inform their doctor promptly."
In addition to the effects on the fetus, letrozole may cause a number of side effects, including hot flashes, joint pain, and fatigue. Long-term use may lead to osteoporosis, which poses a secondary threat to women's health. These potential side effects further emphasize the caution needed when using this medication.
Letrozole can inhibit liver enzymes such as CYP2A6 and CYP2C19, which may affect the metabolism of other drugs. However, no significant interactions have been found with common drugs such as cimetidine and warfarin.
ConclusionIn summary, letrozole is an amazing advancement in medicine, but its contraindications during pregnancy cannot be ignored. This is not only about the health of the patient, but also about the safety of the unborn child. When choosing a treatment option, all possible risks and benefits should be carefully considered. As medicine advances, can we better balance treatments against possible risks?